Posted Apr 30, 2019

At LSC we specialise only in Life Sciences and always keep up to date with leading news, projects and all that’s going on in the industry. As the sector sees continued growth it’s easy to miss some of the major announcements. To make things easier and to ensure you too are well informed we’ve selected and summarised this month’s top Irish Life Science industry news stories below.

Allergan announce €65m investment in Ireland and 63 new jobs for Mayo

Global pharmaceutical company Allergan, which is headquartered in Ireland and operates four facilities here, has announced a €65 million capital investment programme for 2019 to facilitate the continued expansion of the company’s state-of-the art laboratories and manufacturing campuses at Westport in County Mayo and Clonshaugh in north Dublin.

The Westport facility has created 63 new highly skilled pharma jobs, bringing Allergan’s total workforce in Ireland to more than 2,000 across the country. Full article >>

Johnson & Johnson €100m expansion to create 300 jobs in Limerick

Johnson & Johnson is to create an additional 300 jobs as part of a €100 million expansion of the company’s Vision Care facilities at the National Technology Park in Limerick. The IDA Ireland-supported jobs include 100 permanent manufacturing jobs, as well as 200 additional construction posts during the building of the new facility.

Johnson & Johnson currently employs around 1,000 people in Limerick at the largest contact lens manufacturing facility in the world. Full article >>

Edwards Lifesciences doubles investment to €160m in Limerick

American medical device business Edwards Lifesciences  announced last October that it was to invest €80 million in a new technology plant in Limerick.

Investment has now doubled as the firm confirmed this April that total investment will amount to €160 million.

The Limerick facility, at  Plassey National Technology Park, Castletroy will make sophisticated heart valves and create up to 600 medical device jobs. Full article >>

2019 FOYA awards Eli Lilly Kinsale prize for Process Innovation

The Facility of the Year Awards recognize the accomplishments, commitment, and dedication of companies worldwide that demonstrate innovation and the advancement of pharmaceutical science and manufacturing technology.

The Continuous Drug Substance Manufacturing facility of Eli Lilly and Company, a global pharma company was selected as the 2019 Process Innovation Category Award recipient. The Kinsale facility is referred to as Small Volume Continuous (SVC) because it is targeted at pipeline products with an annual volume less than 1.5 metric tonnes.  This innovative facility and process design concepts advance the industry in three specific areas; process analytical technologies and advanced automation, development of new continuous technologies, and significant improvement in process safety and environmental impacts. Based on these reasons, ISPE recognized Lilly with the Award. Stating the facility at Lilly’s Kinsale manufacturing plant clearly shows the future of Active Pharmaceutical Ingredient (API) manufacturing. Full article >>

If you’re looking to be part of this thriving sector, click below to explore contract opportunities in the Life Sciences with LSC today!

Contract jobs in the Life Sciences sector